MetaCap

Bluejay Diagnostics (BJDX) vs Beyond Air (XAIR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

Bluejay Diagnostics is the larger company by market cap ($3.7 million vs $2.2 million), about 1.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BJDX+1.70%XAIR-11.42%
+2%-5%-12%
Oct 7, 20261 yearOct 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BJDX versus XAIR key metrics
MetricBJDXXAIR
Share price$0.8239$2.25
Market cap$3.68M$2.21M
1-day change+1.02%-2.60%
EPS (TTM)$-3.58$-64.40
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$15.12$55.00
52-week low$0.755$2.20
Distance from 52-week high-94.55%-95.91%
Analyst consensus—none
Avg. price target upside—+788.89%
Average volume3.61M222.52K
Shares outstanding4.47M984.41K
Employees654
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Bluejay Diagnostics

BJDX stock →

Bluejay Diagnostics, Inc. operates as a medical diagnostics company.

Health Care · Medical/Dental Instruments · 6 employees

About Beyond Air

XAIR stock →

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company.

Health Care · Medical/Dental Instruments · 54 employees

BJDX vs XAIR FAQ

Which is bigger, Bluejay Diagnostics or Beyond Air?

Bluejay Diagnostics (BJDX) is larger, with a market capitalization of $3.68M compared with $2.21M for Beyond Air (XAIR).

Are Bluejay Diagnostics and Beyond Air in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons